New York’s vibrant neighborhood Tribeca is home to one of the city’s most dynamic incubators, NYU-Polytech Varick. Last week NYU-Polytech Varick hosted a Meetup event on New York’s biotech sector. A panel of speakers including Dr. Liam Ratcliffe of New Leaf Ventures, Michael Lamprecht of Cellanyx Diagnostics, Andrew Koopman of NYU’s New Venture Development Investment, and Alex Fair, the founder of Faircaremd.com and MedStartr, shared their take on what the opportunities and challenges for New York’s biotech sector are.
New York State was ranked second as Biotech center by Business Facilities Magazine in 2005. Healthcare initiatives and funding, such as the NYC Economic Development Corporation’s (NYCEDC) BioAccelerate Program; New York’s Division of Science, Technology and Innovation (NYSTAR); and the Empire State Development’s (ESD) Excelsior Program, are all improvements recently designed to eliminate the “severely anemic” economic support of the biopharmaceutical industry in New York State. But other states, such as California, Texas, Kansas, and Massachusetts, are thriving biotech hubs as well.
To read the full, original article click on this link: What does it take for NYC's biotech sector to sizzle? | The Next Silicon Valley
